Gardasil has been shown to be highly effective in preventing infections with HPV types 6, 11, 16, and 18. Clinical trials and post-licensure studies have demonstrated that the vaccine can prevent nearly 100% of cervical precancers and genital warts caused by these HPV types. Its widespread use has led to a marked reduction in the incidence of these conditions in vaccinated populations.
